Skip to main content
. 2020 Mar 25;12(6):379–392. doi: 10.4155/bio-2019-0303

Table 2. . Intra-assay (six repeated analyses within one experiment during 20 h with samples stored in sample manager) and interassay validation.

Compound Linearity (R2) LOD–LLOQ % Matrix effects Intra-assay (n = 6 during 20 h in +4°C) Interassay (n = 3)
        Accuracy (% of target) Precision (RSD%) Accuracy (% of target) Precision (RSD%)
        Conc A Conc B Conc A Conc B Conc A Conc B Conc A Conc B
TRP 0.996 10.0–10.0 -8.4 102 108 1 1 101 107 2 2
L-KYN 0.997 0.1–0.25 -4.1 96 115 1 1 95 114 1 3
KYNA 0.998 0.1–0.5 -12.1 102 106 1 1 102 106 2 1
QUIN 0.998 2.5–5.0 3.3 95 97 2 1 94 97 1 4
PIC 0.979 1.0–5.0 12.5 112 89 3 5 113 87 4 1
NAA 0.996 2.5–10 2.4 94 93 3 1 92 92 14 3
NA 0.997 1.0–5.0 -4.0 101 96 9 1 97 95 2 1
3-HANA 0.963 1.0–5.0 -3.9 136 97 4 2 140 97 8 8
XA 0.989 2.5–10.0 6.0 95 85 2 2 97 86 7 3
3-HK 0.997 0.25–1.0 23.4 94 91 1 2 95 92 1 2

Intra-assay (six repeated analyses within one experiment during 20 h with samples stored in sample manager) and interassay (three independent experiments within 2 days, all) validation results. Concentration A: two-times endogenous levels, B: ten-times endogenous CSF levels for all metabolites in blank CSF. Matrix effects calculated from ratio of IS area in matrix/IS are in blank sample). LOD–LLOQ concentration of TRP is in μM, all other metabolite (L-KYN, KYNA, QUIN, PIC, NAA, NA, 3-HANA, XA and 3-HK) concentrations are in nM.

3-HANA: 3-Hydroxyanthranilic acid; 3-HK: 3-Hydroxykynurenine; CSF: Cerebrospinal fluid; IS: Internal standard; KYNA: Kynurenic acid; L-KYN: L-Kynurenine; LLOQ: Lower limit of quantification (S/N ratio of ten); LOD: Limit of detection (S/N ratio of three); NA: Nicotinic acid; NAA: Nicotine amide; PIC: Picolinic acid; QUIN: Quinolinic acid; RSD: Relative standard deviation; TRP: Tryptophan; XA: Xanthurenic acid.